Bayer Shares Plummet to 20-Year Low Amid Mounting Losses

The company's financial struggles are exacerbated by weak agricultural performance and ongoing legal battles from the Monsanto acquisition.

Bayer's stock fell by over 10%, reaching its lowest point in two decades due to disappointing third-quarter results.
The company reported a net loss of nearly €4.2 billion, mainly due to substantial write-downs in its agriculture division.
Legal challenges from Monsanto's glyphosate products continue to weigh heavily on Bayer, with lawsuits climbing to approximately 177,000 cases.
CEO Bill Anderson announced a downward revision of the company's earnings forecast, now expecting €10 to €10.3 billion for 2024.
The acquisition of Monsanto has led to €12.9 billion in write-downs since 2018, significantly impacting Bayer's market value.